Citations

Clear

415 citation(s) found for "Black, DF".

Abstract 6289: Targeted sequencing of common cancer susceptibility genes reveals germline variants in African prostate cancer patients.
Onyia, Abimbola F. , Okwuchi, Freeman, Divine, Sylvester, Olasehinde, Olutola Esther, Yahaya, Ayinde, Salako, A A, Zakari, Aminu, Bassey, Iya, Petershie, Bernard, GANDAHO, Isidore, Brun, Luc, Sanni, Tore, Coulibaly, Sidi, Coulibaly, Noel, Fakayode, Michael, Issoufou, Coulibaly, Gbonon, Valérie Mbengue, Benjamin, Kouamé, Evrard, Yao, Coleman, Peter, Ajumbo, Victor, Wattanga, Lilac, Nyambega, Benson Ochieng, Odedina, Folakemi T., Campos, Opeyemi Christianah De , Titiloye, Nicholas Akinwale , Gandaho, Isidore, Noel, Coulibaly, Fakayode, Michael Karington , Kouame, Benjamin , Cassell, Ayun , Nyambega, Benson , Rotimi, Solomon O.

Mayo Clinic

Cancer Research | April 3, 2026 | Volume: 86 | Issue: 7_Supplement | Pages: 6289-6289

10.1158/1538-7445.am2026-6289 Get It

Abstract Background: Prostate cancer (PCa) is the leading cause of cancer-related deaths globally and disproportionately affects men of African ancestry. African men often present at younger ages and with more aggressive disease, and approximately half of the PCa risk has been attributed to genetic factors. Africa is the most genetically diverse region of the world, and even within the continent, populations show important differences in allele frequencies and patterns of pathogenic variation. Despite this diversity, African men remain underrepresented in genomic studies, creating significant gaps in knowledge that limit precision medicine efforts. Methods: A total of 182 prostate cancer patients were recruited from teaching hospitals in Benin, Côte d’Ivoire, Ghana, Kenya and Nigeria. 50 cancer susceptibility genes using the Aviseq ONCO50 panel and the Illumina MiSeq platform. Variant calling was performed using an in-house Snakemake workflow, followed by additional bioinformatic steps to distinguish true PMS2 variants from PMS2CL-related artifacts. Pathogenicity assessment relied on annotations from ClinVar and LOVD databases. Results: Pathogenic and likely pathogenic variants were detected in 31.3% of the study group identified in 26 genes. The five most frequently altered genes were RAD50, PTCH1, MSH6, MUTYH, and NF1. Nigerian patients accounted for 52.6 percent of all pathogenic variants, with recurrent alterations observed in MSH6, MUTYH, NF1, and PTCH1. In contrast, pathogenic BRCA1 and BRCA2 variants were observed primarily in patients from Kenya, Benin, and Côte d’Ivoire. Several frameshift, nonsense, and splice-site variants identified in this study have not been previously reported in African populations.[SR1] Conclusion: This study provides one of the most detailed assessments of inherited cancer susceptibility gene variants in African PCa patients. The findings reveal substantial regional variation in the spectrum of pathogenic variants and highlight population-specific genomic signatures that may contribute to the unequal burden of PCa in men of African ancestry. These data emphasize the importance of expanding genomic research efforts within Africa to strengthen precision oncology and reduce global PCa disparities. Citation Format: Abimbola F. Onyia, Freeman Okwuchi, Opeyemi C. De Campos, Sylvester Divine, Olutola Olasehinde, Ayinde Yahaya, Ayo Salako, Aminu Zakari, Iya Bassey, Nicholas Titiloye, Bernard Petershie, Isidore GANDAHO, Luc Brun, Tore Sanni, Safiatou Coulibaly, Noel Coulibaly, Michael Fakayode, Coulibaly Issoufou, Valérie Gbonon, Kouame Benjamin, Yao Evrard, Peter Coleman, Ayun Cassell, Victor Ajumbo, Lilac Wattanga, Benson Ochieng Nyambega, Folakemi T. Odedina, Solomon Rotimi. Targeted sequencing of common cancer susceptibility genes reveals germline variants in African prostate cancer patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6289.
Disclosure of Family Cancer History in Black Families With Breast and Ovarian Cancer
Halyard, Michele Y. , James, Sarah, Kelly, Marion, Phillips, Daphne, Kelly, Marion K, Phillips, Daphne T, Riggan, Kirsten A. , Yap, Jane Q. , James, Sarah E., Phillips, Daphne T., Allyse, Megan

Mayo Clinic

Cancer Nursing | March 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/ncc.0000000000001554 | PMID 41812040 Get It

Background: Sharing of family cancer history (FCH) in Black families has been documented as lower than in other populations. There has been limited exploration as to the factors and circumstances that facilitate or hinder FCH communication in these communities. Objective: To explore intersecting factors influencing FCH discussion in Black families with a breast or ovarian cancer diagnosis. Interventions/Methods: We conducted qualitative interviews with socioeconomically diverse breast and ovarian cancer patients or family members. Interviews were thematically analyzed for iterative themes on FCH. Results: A total of 107 participants completed an interview. Discussion of FCH was reported as being influenced by several factors, including relationship and family dynamics, personality of family members, involvement in caregiving and support, and perceived importance and responsibility of communicating FCH for cancer prevention. Participants also described how inequitable access to medical care influenced disclosure of a cancer diagnosis, and socioeconomic concerns can influence family communication and documentation of FCH in the medical record. Conclusion: Our analysis indicates that disclosure of FCH is improving over time as access to healthcare has increased for Black families. Implications for Oncology Nursing Practice: Strategies to collect FCH outside of clinic settings, such as digital tools or chatbots, should be considered for increased capture of cancer pedigrees in families where discussion is limited. Patient education on options for preventative care and communications tools may assist patients with family discussions, although patients with adverse social determinants of health are likely to experience additional barriers to genetic screening based on FCH alone.
Collaborative large language models (LLMs) are all you need for screening in systematic reviews
Parmar, Mihir, Naqvi, Syed Arsalan Ahmed , Warraich, Kainat , Saeidi, Amir, Rawal, Samarth, Faisal, Kunwer Sufyan , Kazmi, Syeda Zainab , Fatima, Maurish , He, Huan, Safdar, Mohammad, Liu, Wei, Haddad, Tufia C., Wang, Zhen , Murad, Mohammad Hassan, Baral, Chitta, Haddad, Tufia, Riaz, Irbaz Bin , Saeidi, Amir, Haddad, Tufia C.

Mayo Clinic

No container title available | February 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.02.07.26345640 | PMID 41757212 Get It

Abstract Background The ability of large language models (LLMs) to work collaboratively and screen studies in a systematic review (SR) is under-explored. Hence, we aimed to evaluate the effectiveness of LLMs in automating the process of screening in systematic reviews. Methods This is an observational study which included labeled data (title and abstracts) for five SRs. Originally, two reviewers screened the citations independently for eligibility. A third reviewer cross-checked each citation for quality assurance. GPT-4, Claude-3-Sonnet, and Gemini-Pro-1.0 were used using zero-shot chain-of-thought prompting. Collaborative approaches included (i): conflict resolution using benefit of the doubt, (ii) majority voting using an independent third LLM and (iii) conflict resolution using an informed third LLM. Performance was assessed using accuracy, precision for exclusion, and recall for inclusion. Work saved over samples (WSS) was computed to estimate the reduction in manual human effort. Results A total of 11300 articles were included in this study. The individual models, GPT-4, Claude-3-Sonnet, and Gemini-Pro-1.0 exhibited a high precision for exclusion, achieving 99.7%, 99.7%, and 99.2% and high recall for inclusion achieving 95.5%, 96.6% and 85.7%, respectively. However, the collaborative approach utilizing the two best-performing models (GPT-4 and Claude-3S) achieved an average precision of 99.9% and a recall of 98.5% (across all collaborative approaches). Furthermore, the proposed collaborative approach resulted in an average WSS of 63.5%, compared to the average WSS of 45.2% for individual models. Conversational LLM interactions showed a consistent pattern of results. Limitations This study was limited due to reliance on proprietary models, and evaluation on oncology datasets. Conclusion Evidence shows that collaborative LLMs enable efficient, high-performing screening in systematic reviews, supporting continuous evidence updates. Primary funding source NIH (U24CA265879-01-1) and Carolyn-Ann-Kennedy-Bacon Fund.
Editorial Comment
Black, Amanda E., Lyon, Timothy D. , Kahn, Amanda E. , Lyon, Timothy D , Kahn, Amanda

Mayo Clinic

Journal of Urology | February 3, 2026 | Volume: 215 | Issue: 5 | Pages: 543-543

10.1097/ju.0000000000004941 | PMID 41631584 Get It

Influence of Social Media on Food Choices and Consumption Patterns of Undergraduates in a Nigerian University: A Cross-Sectional Study
Okoruwa, Juliet Obiageli , Ovedje, Tina E., Adeleke, F. N., Oladosu, G., Akinboboye, Praise O., Bolajoko, Opeyemi , Oladosu, Gbenga S. , Bolajoko, Opeyemi

Mayo Clinic

BioSocial Health journal | January 31, 2026 | Volume: 2 | Issue: 3 | Pages: 109-115

10.34172/bshj.83 Get It

Introduction: Social media plays a significant role in shaping the behaviors of undergraduates, including food choices. This study examined the influence of social media on food choices and consumption patterns among undergraduates at a Nigerian university. Methods: A descriptive cross-sectional study of 400 students was conducted using multistage sampling. Data were collected via a pre-tested, interviewer-administered questionnaire on sociodemographic, food consumption, social media use, and its perceived influence on food choices. Analyses were conducted in SPSS v29, reporting means, standard deviations, frequencies, and percentages. Binary logistic regression assessed associations between social media use and food consumption, with significance at P<0.05. Results: Respondents’ mean age was 21.17 ± 2.00 years, with 49.8% aged 15–20. WhatsApp (84.2%) and YouTube (80.7%) were the most used platforms. Over 60% reported that social media influenced their food choices. Confectioneries (70.5%), vegetables (62.5%), and oils (62.3%) were commonly consumed, while alcohol was least consumed (14.5%). Higher social media use was significantly associated with frequent meat and poultry consumption (OR=2.18, P=0.018) and lower odds of oil consumption (OR=0.42, P=0.002). Conclusion: The findings highlight the influence of social media on students’ diets, suggesting the need for nutrition professionals to promote healthier food choices through social platforms.
DPYD Sequencing Identifies More Clinically Relevant Variants as Compared to Targeted Genotyping
Moyer, A. M., Lundquist, Emma, Thoreson, Emily , Kluge, Michelle L. , Kotzer, Katrina E. , Love, Elyse M, Glessner, Heather L, Arneson, Sarah, Langman, Loralie J., Baudhuin, Linnea M. , Black, John Logan, Moyer, AM , Thoreson, Emily K, Arneson, Sarah K, Lundquist, Emma L., Love, Elyse M., Glessner, Heather Dean, Black, John L.

Mayo Clinic

Clinical Chemistry | January 13, 2026 | Volume: 72 | Issue: 6 | Pages: 662-669

10.1093/clinchem/hvag007 | PMID 41802113 Get It

Abstract Background DPYD testing can identify patients at risk for severe toxicity when a standard fluoropyrimidine antineoplastic dose is prescribed. Sequencing-based methods detect rare variants, which require classification. Methods DPYD sequencing results over a 9-year period through to 2024 were analyzed. The dataset was filtered to calculate the positive test rate for different genotyping strategies, including targeted analysis of the Association for Molecular Pathology (AMP) Tier 1 and 2 recommended alleles, and as compared to sequencing. Variant classifications based on the laboratory’s clinical protocol were compared to ClinVar classifications and designations by the Clinical Pharmacogenetics Implementation Consortium (CPIC) expert panel. Results A DPYD variant was reported in 12.79% (896/7003) of those tested, with 2.53% (170/7003) of all reports including a variant of uncertain significance. Had only AMP Tier 1 or both Tier 1 and 2 been tested, 9.30% and 9.44% of patients would have received a positive report, respectively. Among the 281 unique, non-Tier 1/Tier 2 variants encountered during sequencing, &gt;80% were not classified by the CPIC expert panel, while &gt;48% were not reported in ClinVar. Variant classifications by our laboratory and those in ClinVar were generally concordant with the CPIC expert panel, despite the lack of a standardized classification system. Conclusions While AMP Tier 1 genotyping would have identified most patients at risk for fluoropyrimidine toxicity, sequencing is more comprehensive, identifying 26% more reportable variants compared to targeted genotyping. A standard framework for pharmacogenomic variant classification could facilitate consistent variant classification and a transition from targeted genotyping to sequencing.
Tau PET imaging in Black and Latino participants with and without cognitive impairment
Day, Gregory S, Przybelski, Scott A. , Jain, Manoj K, Lachner, Christian, Piura, Yoav , Aduen, Paula, Schecter, Leah, Fought, Angela J. , Diaz‐Galvan, Patricia, Lowe, VJ, Schwarz, Christopher G, Boeve, Brad F, Petersen, Ronald, Kantarci, Kejal, Graff‐Radford, Neill R., Diaz‐Galvan, Patricia , Diaz-Galvan, Patricia , Day, Gregory S. , Lachner, Christian , Schwarz, Christopher G. , Petersen, Ronald C. , Kantarci, Kejal , Graff‐Radford, Neill R.

Mayo Clinic

Alzheimer's & Dementia | January 10, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_106309 Get It

Abstract Background Tau‐PET neuroimaging is increasingly applied to diagnose and stage, track progression, and assess response to putative disease‐modifying treatments in individuals with Alzheimer disease. However, it remains to be seen whether findings established in predominantly non‐Hispanic White (nHW) cohorts will generalize to Black and Latino participants who are underrepresented in dementia research. Method Community‐dwelling Black ( n = 83) and Latino participants ( n = 27) completed MRI (with quantification of white matter hyperintensity volumes), and amyloid‐ (PiB or florbetapir) and tau‐ (flortaucipir) PET brain imaging as part of a longitudinal study of memory and aging at Mayo Clinic in Florida. Global and regional tau‐PET standardized uptake value ratios (normalized to the cerebellar crus) were determined in Black and Latino participants and compared with findings from an independent cohort of nHW participants ( n = 110), 1:1‐matched for age, sex, education, and global Clinical Dementia Rating®. Conditional logistic modeling compared 47 regions of interest, adjusted for false discovery rate. Relevant associations between flortaucipir retention and clinical outcomes were assessed using Spearman rank correlations. Result Eighty‐three Black (mean 72±10.8‐years‐old, 63% female, 33% cognitively impaired) and 27 Latino participants (mean 65.8‐years‐old, 56% female, 11% cognitively impaired) completed neuroimaging. Data were compared with findings in 110 matched nHW individuals. Global tau‐PET burden was similar between matched cohorts (Black and nHW participants, mean SUVR: 1.34±0.39 vs 1.36±0.37, p = 0.71; Latino and nHW participants, mean SUVR: 1.17±0.09 vs 1.20±0.11, p = 0.66). Lower flortaucipir uptake was noted in the caudate ( p = 0.005) and putamen ( p = 0.022) of Black/Latino participants (vs nHW), although differences attenuated following adjustment for white matter hyperintensity volume. Global flortaucipir retention increased with age (Black: Rho=0.31; Latino: Rho=0.46; nHW: Rho=0.27; p <0.05), amyloid Centiloids (Black: Rho=0.65; Latino: Rho=0.41; nHW: Rho=0.58; p <0.05), and cognitive impairment (i.e., Clinical Dementia Rating® Sum‐of‐Box scores, Black/Latino: Rho=0.31, p = 0.07; nHW: 0.76, p <0.001). Conclusion Tau‐PET patterns were similar across ethnoracial groups after adjusting for white matter hyperintensity volumes—a biomarker of small vessel disease. Flortaucipir retention increased with age, amyloid accumulation, and cognitive impairment across all cohorts. These findings affirm the clinical and research applications of tau PET in diverse cohorts. Acknowledgements : Flortaucipir precursor and technology was supported by Avid Radiopharmaceuticals.
Plasma Alzheimer's Disease Biomarker Associations with eGFR in Black and White Older Adults
Sullivan, Kevin, Blackshear, Chad , Knopman, David S., Syrjanen, Jeremy A. , Vassilaki, Maria , Jack, Clifford R., Petersen, Ronald, Windham, Gwen Gwen, Mosley, Thomas H., Griswold, Michael E., Bornhorst, Joshua , Knopman, David S. , Figdore, Daniel J. , Jack, Clifford R. , Petersen, Ronald, Mosley, Thomas H. , Algeciras‐Schimnich, Alicia , Griswold, Michael

Mayo Clinic

Alzheimer's & Dementia | January 9, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_107141 Get It

Abstract Background Decreased kidney function, indicated by a lower estimated glomerular filtration rate (eGFR), may affect interpretation of Alzheimer's disease (AD) blood biomarkers, including phosphorylated tau ( p ‐tau) and amyloid‐beta (Aβ) peptides, due to altered clearance. However, there is limited data available to determine the influence of eGFR on these biomarkers and whether it differs by biomarker or assay type, especially in racially diverse studies of community‐based older adults. Methods We used data from 557 participants in the Mayo Clinic Study of Aging (Rochester, MN n = 182; age 79±8 years; 36.3% Female, White participants) and the UMMC MIND Center‐Mayo Clinic Study of Aging (Jackson, MS n = 375; age 69±8 years; 73% Female 27% Black participants). eGFR was determined using the 2021 CKD‐EPI Creatinine equation. Plasma biomarkers were measured using the Lumipulse immunoassays for p ‐tau217, Aβ42, and Aβ40 (Fujirebio Diagnostics; n = 420); or the mass spectrometry‐based PrecivityAD2 assay (C2N Diagnostics; n = 253) for p ‐tau217, np‐tau217, Aβ42, and Aβ40. Common ratio values were calculated. Aβ42/40 measures were inverted so higher values are worse for all biomarkers. Log base‐2 transformed regression analysis related eGFR to each single analyte and ratio; coefficients (95% CI) reflect estimated doubling in biomarker per doubling in eGFR. Group specific [MN White ( n = 182), MS White ( n = 224), MS Black ( n = 151) participants] estimates are reported, as the distribution of social determinants of health can vary across populations and locations. Results Lower eGFR was associated with higher (worse) AD‐plasma biomarkers, and group stratified estimates were mostly consistent (Figure 1). Ratios of biomarkers diminished but did not entirely alleviate associations with eGFR. For example, MN White participants’ C2N p ‐tau217 association of ‐1.47 (‐1.94, ‐1.00), was attenuated to ‐0.67 (‐1.11, ‐0.22), when using p ‐tau217/np‐tau217. Conclusions Kidney function may be associated with AD‐plasma biomarker values, even with common ratio corrections. There was not strong evidence for highly differential associations of eGFR by race/site categories, though sample sizes are currently limited. The implications for diagnosis and risk classification need to be explored further to support health equity. Optimal consideration of comorbidities on blood biomarker concentrations must continue to be informed by investigation in large, racially and ethnically diverse, community‐based studies.
Linking retinal amyloid imaging to cognition and hippocampal integrity – a retrospective cohort analysis
Gonzales, Mitzi M., Fuchs, Dieu‐Trang, Doustar, Jonah , Koronyo, Yosef, Sherman, Dale , Lyden, Patrick D. , Sicotte, Nancy L. , Black, Keith L, Dumitrascu, Oana M. , Black, Keith L. , Gonzales, Mitzi M. , Gonzales, Mitzi , Koronyo, Yosef, Black, Keith L , Kremen, Sarah , Koronyo‐Hamaoui, Maya

Mayo Clinic

Alzheimer's & Dementia | December 26, 2025 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_102028 Get It

Abstract Background Sensitive, accessible biomarkers of the pathologies underlying Alzheimer's disease and related dementias (ADRD) are critical for accurate diagnosis, deeper understanding of disease mechanisms, and development of new therapies with validated target engagement. The retina is connected to the brain via the optic nerve, which may facilitate the transmission and spread of amyloid beta (Aβ) and tau species. In postmortem studies, retinal Aβ deposits have been associated with neuritic Aβ‐plaque and neurofibrillary tangle burden, particularly in the entorhinal and temporal cortices. The goal of the current study was to evaluate associations between retinal perivascular amyloid and cognition, as well as to explore effect modification by hippocampal volumetry. Method Participants, aged ≥40 years, underwent retinal imaging, brain MRI, FDG‐PET, and a comprehensive neuropsychological assessment. Retinal amyloid imaging was conducted following curcumin ingestion and pupil dilation using a confocal scanning laser ophthalmoscope. Perivascular Aβ plaque counts were quantified in the superotemporal peripheral region following manual identification and tracking of retinal arteries and veins. Associations between retinal perivascular Aβ plaque counts with cognitive domains were evaluated using linear regression models adjusted for age, sex, and estimated premorbid functioning. Where significant associations were detected ( p ‐value<0.05), effect modification by hippocampal volumetry was examined with additional adjustment for intracranial volume. Result The sample included 26 participants (mean age 65±7 years, 50% female). Higher amyloid plaque counts in the perivascular secondary small and tertiary branches and in the periarteriolar tertiary branch were associated with poorer verbal and visual memory (Table 1). Significant interactions were observed between amyloid plaque count in the perivascular secondary small branch (β(95% Confidence Interval) = 0.397(0.037‐0.756), p = 0.033) and periarteriolar tertiary branch (β(95% Confidence Interval) = 0.756(0.165–1.346), p = 0.017) with hippocampal volumetry for visual memory. Conclusion Our pilot study provides preliminary evidence that perivascular Aβ accumulation in smaller vessels of the superotemporal retina may be a marker of memory impairment that may interact synergistically with hippocampal atrophy. Longitudinal studies consisting of multimodal ophthalmic assessments, brain imaging, ADRD biofluid markers, and cognitive testing will be necessary to capture the temporal sequence of retinal pathological changes and their associations with those in the brain.